Agebox iKids-Growth — Class II drug recall D-0344-2026
Ongoing recall by Agebox, reported 2026-03-04, distributed nationwide. Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
| Recall number | D-0344-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Agebox, Wilmington, DE, United States |
| Recall initiated | 2025-10-28 |
| Classified | 2026-02-25 |
| Reported by FDA | 2026-03-04 |
| Distributed | Nationwide (US) |
| Quantity | 665 bottles |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 00850065597010 |
| Lot numbers | 23101201, 24080801, 25020701 |
| Expiration dates | 2026-09, 2027-07, 2028-01 |
Product
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 8 50065 59701 0
Reason for recall
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0344-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.